Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: A Radiation Therapy Oncology Group 9609 phase II study

David S. Ettinger, Brian A. Berkey, Ross A. Abrams, James Fontanesi, Mitchell Machtay, Philip J. Duncan, Walter J. Curran, Benjamin Movsas, Roger W. Byhardt

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: A Radiation Therapy Oncology Group 9609 phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences